×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Neuropeptide and Endocrine Signaling in CBS/PSP
therapeutic
1,473 words
KG: ent-dise-bfd8f32d
2026-03-24
kind:therapeutic
section:therapeutics
state:published
Contents
Neuropeptide and Endocrine Signaling in CBS/PSP
💊
Therapeutic Info
Name
Neuropeptide and Endocrine Signaling in CBS/PSP
Summary
Advanced neuropeptide signaling analysis covering orexin, NPY, CGRP, vasopressin, oxytocin, PACAP, somatostatin, and therapeutic implications for CBS/PSP
Knowledge Graph
Related Hypotheses (30)
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Smartphone-Detected Motor Variability Correction
Score: 0.56
Adenosine-Astrocyte Metabolic Reset
Score: 0.56
Purinergic Signaling Polarization Control
Score: 0.55
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Retinal Vascular Microcirculation Rescue
Score: 0.54
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53
Senescence-Associated Myelin Lipid Remodeling
Score: 0.51
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat
Score: 0.50
Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.50
Ganglioside Rebalancing Therapy
Score: 0.50
Orexin-Microglia Modulation Therapy
Score: 0.49
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.49
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Microglial Purinergic Reprogramming
Score: 0.48
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.48
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.48
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.48
Ocular Immune Privilege Extension
Score: 0.47
Sphingomyelin Synthase Activators for Raft Remodeling
Score: 0.47
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45
Reelin-Mediated Cytoskeletal Stabilization Protocol
Score: 0.45
Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution
Score: 0.45
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
Show 25 more
Related Analyses (13)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Show 8 more
Related Experiments (24)
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.40
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40
Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40
Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40
Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.40
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40
Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40
mPFC PACAP knockdown validation experiment
exploratory · proposed · Score: 0.90
Synaptic plasticity and protein expression analysis in mPFC
exploratory · proposed · Score: 0.85
PACAP agonist rescue experiment in sleep-deprived mice
exploratory · proposed · Score: 0.80
Show 19 more
Key Papers (1)
Assessment of the Spatial Distribution of Moisture Content in Granular
Sensors (Basel, Switzerland) 2024
See Also (15)
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 34 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 34 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 34 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 34 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 34 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 34 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 34 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 35 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 35 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 35 hypotheses
Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 34 hypotheses
Tau Kinase Signaling Cascade in Alzheimer's Disease
mechanism · Pages share 34 hypotheses
T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 34 hypotheses
Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 34 hypotheses
synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 34 hypotheses
Show 10 more